These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 27028912

  • 1. Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol.
    Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group.
    N Engl J Med; 2016 Mar 31; 374(13):1221-31. PubMed ID: 27028912
    [Abstract] [Full Text] [Related]

  • 2. Differential Effect of Plasma Estradiol on Subclinical Atherosclerosis Progression in Early vs Late Postmenopause.
    Sriprasert I, Hodis HN, Karim R, Stanczyk FZ, Shoupe D, Henderson VW, Mack WJ.
    J Clin Endocrinol Metab; 2019 Feb 01; 104(2):293-300. PubMed ID: 30272234
    [Abstract] [Full Text] [Related]

  • 3. Effect of menopausal hormone therapy on arterial wall echomorphology: Results from the Early versus Late Intervention Trial with Estradiol (ELITE).
    Karim R, Xu W, Kono N, Sriprasert I, Li Y, Yan M, Stanczyk FZ, Shoupe D, Mack WJ, Hodis HN.
    Maturitas; 2022 Aug 01; 162():15-22. PubMed ID: 35474254
    [Abstract] [Full Text] [Related]

  • 4. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
    Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW.
    Menopause; 2015 Apr 01; 22(4):391-401. PubMed ID: 25380275
    [Abstract] [Full Text] [Related]

  • 5. Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial.
    Harman SM, Black DM, Naftolin F, Brinton EA, Budoff MJ, Cedars MI, Hopkins PN, Lobo RA, Manson JE, Merriam GR, Miller VM, Neal-Perry G, Santoro N, Taylor HS, Vittinghoff E, Yan M, Hodis HN.
    Ann Intern Med; 2014 Aug 19; 161(4):249-60. PubMed ID: 25069991
    [Abstract] [Full Text] [Related]

  • 6. Use of oral estradiol plus vaginal progesterone in healthy postmenopausal women.
    Sriprasert I, Mert M, Mack WJ, Hodis HN, Shoupe D.
    Maturitas; 2021 Dec 19; 154():13-19. PubMed ID: 34736575
    [Abstract] [Full Text] [Related]

  • 7. Heart fat and carotid artery atherosclerosis progression in recently menopausal women: impact of menopausal hormone therapy: The KEEPS trial.
    El Khoudary SR, Venugopal V, Manson JE, Brooks MM, Santoro N, Black DM, Harman M, Naftolin F, Hodis HN, Brinton EA, Miller VM, Taylor HS, Budoff MJ.
    Menopause; 2020 Mar 19; 27(3):255-262. PubMed ID: 32015261
    [Abstract] [Full Text] [Related]

  • 8. The association of hysterectomy with or without ovarian conservation with subclinical atherosclerosis progression in healthy postmenopausal women.
    Chen IJ, Shoupe D, Karim R, Stanczyk FZ, Kono N, Sriprasert I, Hodis HN, Mack WJ.
    Menopause; 2023 Jul 01; 30(7):692-702. PubMed ID: 37192828
    [Abstract] [Full Text] [Related]

  • 9. Changes in carotid artery intima-media thickness 3 years after cessation of menopausal hormone therapy: follow-up from the Kronos Early Estrogen Prevention Study.
    Miller VM, Hodis HN, Lahr BD, Bailey KR, Jayachandran M.
    Menopause; 2019 Jan 01; 26(1):24-31. PubMed ID: 30020254
    [Abstract] [Full Text] [Related]

  • 10. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.
    Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP, Estrogen in the Prevention of Atherosclerosis Trial Research Group.
    Ann Intern Med; 2001 Dec 04; 135(11):939-53. PubMed ID: 11730394
    [Abstract] [Full Text] [Related]

  • 11. Postmenopausal Hormone Therapy and Atherosclerosis--Time Is of the Essence.
    Keaney JF, Solomon CG.
    N Engl J Med; 2016 Mar 31; 374(13):1279-80. PubMed ID: 27028919
    [No Abstract] [Full Text] [Related]

  • 12. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.
    Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH, Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group.
    N Engl J Med; 2003 Aug 07; 349(6):535-45. PubMed ID: 12904518
    [Abstract] [Full Text] [Related]

  • 13. Cognitive effects of estradiol after menopause: A randomized trial of the timing hypothesis.
    Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Kono N, Dustin L, Allayee H, Mack WJ.
    Neurology; 2016 Aug 16; 87(7):699-708. PubMed ID: 27421538
    [Abstract] [Full Text] [Related]

  • 14. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML, METEOR Study Group.
    JAMA; 2007 Mar 28; 297(12):1344-53. PubMed ID: 17384434
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of Transdermal Estradiol and Micronized Progesterone in the Prevention of Depressive Symptoms in the Menopause Transition: A Randomized Clinical Trial.
    Gordon JL, Rubinow DR, Eisenlohr-Moul TA, Xia K, Schmidt PJ, Girdler SS.
    JAMA Psychiatry; 2018 Feb 01; 75(2):149-157. PubMed ID: 29322164
    [Abstract] [Full Text] [Related]

  • 16. Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.
    Tremollieres FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C.
    Atherosclerosis; 2000 Nov 01; 153(1):81-8. PubMed ID: 11058702
    [Abstract] [Full Text] [Related]

  • 17. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E, Malinen H, Sundström H, Penttinen J, Kauppila A.
    Acta Obstet Gynecol Scand; 1998 Aug 01; 77(7):758-63. PubMed ID: 9740525
    [Abstract] [Full Text] [Related]

  • 18. Effects of micronized progesterone added to non-oral estradiol on lipids and cardiovascular risk factors in early postmenopause: a clinical trial.
    Casanova G, Spritzer PM.
    Lipids Health Dis; 2012 Oct 09; 11():133. PubMed ID: 23046709
    [Abstract] [Full Text] [Related]

  • 19. Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.
    Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ.
    Menopause; 2005 Oct 09; 12(6):728-33. PubMed ID: 16278616
    [Abstract] [Full Text] [Related]

  • 20. Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.
    Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ.
    J Clin Endocrinol Metab; 2008 Jan 09; 93(1):131-8. PubMed ID: 17925335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.